Sign in Subscribe
Class action lawsuits

Securities Class Action Lawsuit Filed Against Replimune Group, Inc.

Strategic Insights

— 1 min read

Purchasers of Replimune securities between November 22, 2024, and July 21, 2025, may be entitled to compensation due to alleged false and misleading statements made by the company's defendants. A securities class action lawsuit has been filed, and a lead plaintiff must be appointed by September 22, 2025, to direct the litigation. The Rosen Law Firm, which has a track record of success in securities class actions, is encouraging investors to select qualified counsel with meaningful peer recognition.

Key Takeaways:

  • The securities class action lawsuit was filed against Replimune Group, Inc. due to allegedly false and misleading statements made by the company's defendants between November 22, 2024, and July 21, 2025.
  • The lawsuit claims that the defendants recklessly overstated the prospects of the IGNYTE trial, given material issues that they knew or should have known of, which resulted in the U.S. Food and Drug Administration ("FDA") deeming the trial inadequate and not well-controlled.
  • Investors who purchased Replimune securities during the specified period may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement.
  • A lead plaintiff must be appointed by September 22, 2025, to direct the litigation.
  • The Rosen Law Firm, which has a track record of success in securities class actions, is encouraging investors to select qualified counsel with meaningful peer recognition.
  • The firm has recovered hundreds of millions of dollars for investors in the past, including a $438 million settlement in 2019 alone.
  • Founding partner Laurence Rosen was named by Law360 as a Titan of Plaintiffs' Bar in 2020.
  • Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Statistics:

  • The lawsuit claims that the defendants made allegedly false and misleading statements between November 22, 2024, and July 21, 2025.
  • The period of alleged false and misleading statements is approximately 9 months.
  • The Rosen Law Firm has recovered $438 million for investors in a single year (2019).
  • The firm has been ranked in the top 4 each year since 2013.
  • Laurence Rosen, the firm's founding partner, was named a Titan of Plaintiffs' Bar in 2020.

Sources:

  • Newsfile Corp. - August 13, 2025
  • The Rosen Law Firm's website (rosenlegal.com)
  • Law360
  • Lawdragon
  • Super Lawyers

Read more